Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate remains among the most vital tools in modern anaesthesia and sharp pain management across the United Kingdom. As a potent synthetic opioid, its role in the National Health Service (NHS) and personal surgical sectors is well-established, mostly due to its quick start of action and cardiovascular stability. This post provides a comprehensive introduction of fentanyl citrate injection formulations available in the UK, their scientific signs, regulatory landscape, and administration procedures.
What is Fentanyl Citrate?
Fentanyl citrate is a powerful phenylpiperidine-derivative opioid agonist. It was very first synthesized in 1960 and rapidly ended up being a cornerstone of perioperative care. In regards to strength, fentanyl is roughly 50 to 100 times more potent than morphine. Its high lipophilicity allows it to cross the blood-brain barrier rapidly, leading to an almost instant analgesic impact when administered intravenously.
In the UK, fentanyl citrate is primarily used through the parenteral route (injection) for both sedative and analgesic purposes. It works primarily by binding to the mu-opioid receptors in the main nerve system, modifying the perception of pain and the emotional response to it.
Scientific Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is suggested for a number of particular medical situations:
- Analgesic Action: Used throughout short operative procedures and in the healing space.
- Analgesic Supplement: Used during the induction and maintenance of inhalation anaesthesia.
- Neuroleptanalgesia: Often used in combination with a neuroleptic (such as droperidol) to achieve a state of quiescence and minimized awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for patients on mechanical ventilation.
- Pre-medication: To offer sedation and analgesia before the induction of basic anaesthesia.
Available Formulations and Strengths in the UK
The UK market uses a number of solutions of fentanyl citrate, developed to fulfill the varying requirements of surgical and emergency situation departments. learn more are generally provided as clear, colourless options for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Typical Packaging | Producer Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Pack of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Load of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU usage) |
Note: While 50 mcg/ml is the basic concentration, specialised solutions for epidural or intrathecal use might in some cases be prepared by medical facility drug stores under specific protocols.
Pharmacokinetics and Pharmacodynamics
Understanding how the body processes fentanyl is important for safe administration.
- Start of Action: When administered intravenously, the result begins almost immediately, though the maximal analgesic impact might take 3 to 5 minutes.
- Period: A single intravenous dosage of 100 micrograms typically lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is primarily metabolised in the liver via the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dosage is excreted in the urine within 24 hours, primarily as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly managed and usually carried out by anaesthetists or trained professionals in controlled environments.
Dosage Guidelines
Dosage should be horizontal and individualised based on the patient's age, weight, physical status, underlying pathological condition, use of other drugs, and the kind of surgical treatment.
- Low Dose (2 mcg/kg): Useful for small surgeries.
- Moderate Dose (2-- 20 mcg/kg): Used when surgical treatment is more intrusive; requires respiratory monitoring.
- High Dose (20-- 50 mcg/kg): Used during "hassle-free" major surgical procedures (e.g., open-heart surgical treatment) to protect the myocardium from the metabolic needs of stress.
Routes of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer treatments or in the ICU.
- Intramuscular (IM): Less common, but used for pre-medication in particular scenarios.
Regulative Status and Safety
In the United Kingdom, Fentanyl is classified under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is categorized as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be saved in a locked managed drug cabinet.
- Record Keeping: Every administration should be tape-recorded in a Controlled Drugs Register (CDR).
- Damage: Surplus or ended fentanyl needs to be denatured and seen by authorised personnel.
Negative Effects and Adverse Reactions
While extremely efficient, fentanyl citrate carries a danger of considerable negative effects.
- Respiratory Depression: The most serious negative effects, which can result in breathing arrest if not kept an eye on.
- Bradychardia: Often handled with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High dosages can make ventilation hard, needing making use of neuromuscular blocking agents.
- Queasiness and Vomiting: Common in the postoperative period.
- Hypotension: Although more steady than morphine, it can still take place, specifically in hypovolaemic clients.
Comparison with Other Opioids
Clinicians often pick fentanyl over other opioids due to its particular pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Function | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Start | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Period of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Negligible | Substantial | Minimal |
| Primary Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Regularly Asked Questions (FAQ)
1. Is fentanyl citrate injection the same as the fentanyl patches?
No. While they consist of the same active drug, the injection is for instant, intense use in surgical or emergency situation settings. Patches (transdermal delivery) are designed for chronic, long-lasting discomfort management and release the medication gradually over 72 hours.
2. Can fentanyl citrate be used for kids in the UK?
Yes, it is frequently used in paediatric anaesthesia. However, the dose must be strictly computed based upon the kid's weight, and they need to be kept track of closely for respiratory depression.
3. What is the antagonist for fentanyl?
Naloxone is the specific medicinal antagonist utilized to reverse the impacts of fentanyl, including respiratory anxiety. In UK healthcare facilities, naloxone should always be readily offered any place fentanyl is administered.
4. Why is it utilized over morphine in heart surgery?
Fentanyl is chosen in cardiac surgical treatment due to the fact that it does not cause the release of histamine, which can result in vasodilation and hypotension. It provides cardiovascular stability even at high doses.
5. What are the storage requirements?
Fentanyl citrate injection must be kept below 25 ° C and safeguarded from light. As a Schedule 2 drug, it should be kept in a legally compliant CD cabinet.
Fentanyl citrate injection solutions are vital components of the UK's medical toolkit for managing perioperative discomfort and helping with complicated surgeries. Its high strength and fast beginning offer unmatched precision for anaesthetists, supplied that strenuous monitoring and regulative requirements are maintained. By understanding the numerous concentrations and the stringent protocols surrounding its usage, healthcare experts ensure that this powerful medication remains both safe and efficient for patients across the nation.
Disclaimer: This short article is for informational purposes just and does not constitute medical guidance. Healthcare professionals need to always refer to the Summary of Product Characteristics (SmPC) and current BNF standards for the most updated prescribing info.
